Qsam Biosciences is an OTC company with loads of potential in that space. The Austin, Texas-based company trades under the symbol $QSAM.
QSAM uses a unique technology CycloSam (Samarium-153 DOTMP) to clinically stage bone targeting radiopharmaceutical which is developed by IsoTherapeutics Group LLC.
Cyclosam is an already FDA-approved drug.
IsoTherapeutics has recently developed Quadramet which is used for pain palliation.
In short, investors need to know that the combination of radioactive isotope and the chelant DOTMP provides a radioactive dose to the sites of mineral turnover such as bone cancers.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.